Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00386893

Somatosensory Processing in Depression

Influence of Escitalopram on Somatosensory Processing in Patients With Major Depression

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Ludwig-Maximilians - University of Munich · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Aim of this study is to investigate neuronal differences (EEG/evoked potentials; functional MRI) between patients with major depression and healthy controls concerning brain activity after acute pain as well as changes of pain related brain activity during treatment with escitalopram.

Conditions

Interventions

TypeNameDescription
PROCEDUREsimultaneous EEG/fMRIfMRI/EEG recordings
DEVICEfMRI

Timeline

Start date
2006-10-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2006-10-12
Last updated
2015-04-14

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00386893. Inclusion in this directory is not an endorsement.

Somatosensory Processing in Depression (NCT00386893) · Clinical Trials Directory